⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1302305 | 1.00 | — | — | |
| SCHEMBL23041319 | 1.00 | — | — | |
| SCHEMBL9499195 | 0.97 | — | — | |
| SCHEMBL3857933 | 0.82 | AKR1B1 (0.37) | — | |
| SCHEMBL31611656 | 0.82 | AKR1B1 (0.37) | — | |
| SCHEMBL23072256 | 0.82 | AKR1B1 (0.37) | — | |
| SCHEMBL1547638 | 0.82 | AKR1B1 (0.37) | — | |
| SCHEMBL15329241 | 0.77 | AKR1B1 (0.30) | — | |
| SCHEMBL21598343 | 0.77 | AKR1B1 (0.30) | — | |
| SCHEMBL12396667 | 0.75 | AKR1B1 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4438734-A2 | REPROGRAMMING OF CELLS TO A NEW FATE | The Scripps Research Institute (US) | 2024-10-02 | — | — | EP | disclosed |
| EP-3399026-B1 | REPROGRAMMING OF CELLS TO A NEW FATE | SCRIPPS RESEARCH INST (US) | 2024-06-26 | — | — | EP | disclosed |
| US-20220296722-A1 | CONJUGATES AND CONJUGATES FOR USE IN PREVENTING OR TREATING OF BRAIN DAMAGE AND NEURODEGENERATIVE DISEASES | MEDICORTEX FINLAND OY (FI) | 2022-09-22 | — | — | US | disclosed |
| EP-4021510-A2 | CONJUGATES AND CONJUGATES FOR USE IN PREVENTING OR TREATING OF BRAIN DAMAGE AND NEURODEGENERATIVE DISEASES | Medicortex Finland Oy (FI) | 2022-07-06 | — | — | EP | disclosed |
| US-20210189348-A1 | REPROGRAMMING OF CELLS TO A NEW FATE | THE SCRIPPS RESEARCH INSTITUTE | 2021-06-24 | — | — | US | disclosed |
| WO-2021038125-A2 | CONJUGATES AND CONJUGATES FOR USE IN PREVENTING OR TREATING OF BRAIN DAMAGE AND NEURODEGENERATIVE DISEASES | MEDICORTEX FINLAND OY (FI) | 2021-03-04 | — | — | WO | disclosed |
| US-10934528-B2 | Reprogramming of cells to a new fate | THE SCRIPPS RESEARCH INSTITUTE (US) | 2021-03-02 | — | — | US | disclosed |
| US-10308912-B2 | Reprogramming of cells to a new fate | THE SCRIPPS RESEARCH INSTITUTE (US) | 2019-06-04 | — | — | US | disclosed |
| EP-3399026-A1 | REPROGRAMMING OF CELLS TO A NEW FATE | The Scripps Research Institute (US) | 2018-11-07 | — | — | EP | disclosed |
| EP-2580320-B1 | REPROGRAMMING OF CELLS TO A NEW FATE | SCRIPPS RESEARCH INST (US) | 2018-08-01 | — | — | EP | disclosed |
| US-20090324682-A1 | Medical stent provided with inhibitors of atp synthesis | INTERSTITIAL THERAPEUTICS (CH) | 2009-12-31 | — | — | US | disclosed |
| EP-1789107-B1 | MEDICAL STENT PROVIDED WITH INHIBITORS OF ATP SYNTHESIS | INTERSTITIAL THERAPEUTICS (CH) | 2009-05-27 | — | — | EP | disclosed |
| US-20070293439-A1 | Methods and Compositions for Treating Hyperglycemic, Hyperlipidemic, or Hyperinsulinemic Disorders | OHIO UNIVERSITY (US) | 2007-12-20 | — | — | US | disclosed |
| US-20070292478-A1 | Medical Implant Provided with Inhibitors of Atp Synthesis | INTERSTITIAL THERAPEUTICS (CH) | 2007-12-20 | — | — | US | disclosed |
| EP-1789030-A2 | MEDICAL IMPLANT PROVIDED WITH INHIBITORS OF ATP SYNTHESIS | Interstitial Therapeutics (CH) | 2007-05-30 | — | — | EP | disclosed |
| EP-1789107-A2 | MEDICAL STENT PROVIDED WITH INHIBITORS OF ATP SYNTHESIS | Interstitial Therapeutics (CH) | 2007-05-30 | — | — | EP | disclosed |
| WO-2006034468-A9 | METHODS AND COMPOSITIONS FOR TREATING HYPERGLYCEMIC, HYPERLIPIDEMIC, OR HYPERINSULINEMIC DISORDERS | UNIV OHIO (US) | 2006-07-27 | — | — | WO | disclosed |
| WO-2006034468-A2 | METHODS AND COMPOSITIONS FOR TREATING HYPERGLYCEMIC, HYPERLIPIDEMIC, OR HYPERINSULINEMIC DISORDERS | OHIO UNIVERSITY (US) | 2006-03-30 | — | — | WO | disclosed |
| WO-2006024488-A2 | MEDICAL STENT PROVIDED WITH INHIBITORS OF ATP SYNTHESIS | INTERSTITIAL THERAPEUTICS (CH) | 2006-03-09 | — | — | WO | disclosed |
| WO-2006024492-A2 | MEDICAL IMPLANT PROVIDED WITH INHIBITORS OF ATP SYNTHESIS | INTERSTITIAL THERAPEUTICS (CH) | 2006-03-09 | — | — | WO | disclosed |